S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   277.76 (+2.25%)
AAPL   116.00 (+4.32%)
MSFT   204.13 (+0.72%)
FB   278.36 (+3.99%)
GOOGL   1,693.00 (+12.06%)
AMZN   3,195.52 (+1.04%)
TSLA   410.70 (+1.15%)
NVDA   518.03 (+2.56%)
BABA   313.00 (+1.64%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.12 (+0.24%)
AMD   77.95 (+2.03%)
T   26.74 (+0.91%)
F   7.91 (+2.73%)
ACB   4.09 (+6.79%)
GILD   58.26 (-0.78%)
NFLX   502.75 (+3.40%)
NIO   31.56 (+14.72%)
BA   148.26 (+0.08%)
DIS   121.70 (+2.73%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   277.76 (+2.25%)
AAPL   116.00 (+4.32%)
MSFT   204.13 (+0.72%)
FB   278.36 (+3.99%)
GOOGL   1,693.00 (+12.06%)
AMZN   3,195.52 (+1.04%)
TSLA   410.70 (+1.15%)
NVDA   518.03 (+2.56%)
BABA   313.00 (+1.64%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.12 (+0.24%)
AMD   77.95 (+2.03%)
T   26.74 (+0.91%)
F   7.91 (+2.73%)
ACB   4.09 (+6.79%)
GILD   58.26 (-0.78%)
NFLX   502.75 (+3.40%)
NIO   31.56 (+14.72%)
BA   148.26 (+0.08%)
DIS   121.70 (+2.73%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   277.76 (+2.25%)
AAPL   116.00 (+4.32%)
MSFT   204.13 (+0.72%)
FB   278.36 (+3.99%)
GOOGL   1,693.00 (+12.06%)
AMZN   3,195.52 (+1.04%)
TSLA   410.70 (+1.15%)
NVDA   518.03 (+2.56%)
BABA   313.00 (+1.64%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.12 (+0.24%)
AMD   77.95 (+2.03%)
T   26.74 (+0.91%)
F   7.91 (+2.73%)
ACB   4.09 (+6.79%)
GILD   58.26 (-0.78%)
NFLX   502.75 (+3.40%)
NIO   31.56 (+14.72%)
BA   148.26 (+0.08%)
DIS   121.70 (+2.73%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   277.76 (+2.25%)
AAPL   116.00 (+4.32%)
MSFT   204.13 (+0.72%)
FB   278.36 (+3.99%)
GOOGL   1,693.00 (+12.06%)
AMZN   3,195.52 (+1.04%)
TSLA   410.70 (+1.15%)
NVDA   518.03 (+2.56%)
BABA   313.00 (+1.64%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.12 (+0.24%)
AMD   77.95 (+2.03%)
T   26.74 (+0.91%)
F   7.91 (+2.73%)
ACB   4.09 (+6.79%)
GILD   58.26 (-0.78%)
NFLX   502.75 (+3.40%)
NIO   31.56 (+14.72%)
BA   148.26 (+0.08%)
DIS   121.70 (+2.73%)
Log in
NASDAQ:TGAN

Transphorm Stock Forecast, Price & News

$3.40
+0.40 (+13.33 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$2.60
Now: $3.40
$4.00
50-Day Range
$3.00
MA: $4.50
$5.50
52-Week Range
$2.60
Now: $3.40
$50.00
Volume9,358 shs
Average Volume3,335 shs
Market Capitalization$119.47 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Transphorm, Inc. designs and manufactures gallium nitride (GaN) field effect transistors. It offers products for various high-voltage power conversion applications, such as server/storage products, PV inverters, automotive products, and motor control. The company offers products through sales representatives and distributors in the Americas, the EMEA, Japan, China and ASEAN, Korea, and Taiwan. Transphorm, Inc. was founded in 2007 and is based in Goleta, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars

Industry, Sector and Symbol

Industry Semiconductor Equipment & Materials
Sub-IndustryN/A
Current SymbolNASDAQ:TGAN
CUSIPN/A
CIKN/A
Phone805-456-1300
Employees100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$119.47 million
Next Earnings DateN/A
OptionableNot Optionable
$3.40
+0.40 (+13.33 %)
(As of 10/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TGAN News and Ratings via Email

Sign-up to receive the latest news and ratings for TGAN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Transphorm (NASDAQ:TGAN) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Transphorm?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Transphorm in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Transphorm
.

What price target have analysts set for TGAN?

2 analysts have issued 1-year price targets for Transphorm's stock. Their forecasts range from $8.00 to $8.00. On average, they expect Transphorm's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 135.3% from the stock's current price.
View analysts' price targets for Transphorm
.

Who are some of Transphorm's key competitors?

What other stocks do shareholders of Transphorm own?

Who are Transphorm's key executives?

Transphorm's management team includes the following people:
  • Prof. Umesh K. Mishra Ph.D., Co-Founder, Chairman & CTO (Age 62)
  • Mr. Mario Alberto Rivas, CEO & Director (Age 65)
  • Mr. Primit A. Parikh Ph.D., Co-Founder & COO (Age 48)
  • Mr. Cameron McAulay, Chief Financial Officer (Age 44)
  • Mr. Randy Berg, HR Leader

What is Transphorm's stock symbol?

Transphorm trades on the NASDAQ under the ticker symbol "TGAN."

How do I buy shares of Transphorm?

Shares of TGAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Transphorm's stock price today?

One share of TGAN stock can currently be purchased for approximately $3.40.

How big of a company is Transphorm?

Transphorm has a market capitalization of $119.47 million. Transphorm employs 100 workers across the globe.

What is Transphorm's official website?

The official website for Transphorm is www.transphormusa.com.

How can I contact Transphorm?

The company can be reached via phone at 805-456-1300.

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.